This information was published on 2025-05-28T00:04:46 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2514067 (IR 1767777) |
| (220) |
27 Dec 2024
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis. Class 45 Licensing services, namely, licensing of pharmaceutical intellectual property rights to third parties. |
| (540) | MADRIGAL PHARMACEUTICALS |
| (550) | Word |
| (730) |
Madrigal Pharmaceuticals, Inc.
|
Find out more about publications on the About page.